Skip to main content
All lobbying filings

COMMUNITY ONCOLOGY ALLIANCE

Lobbying for COMMUNITY ONCOLOGY ALLIANCE

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $218,800.00 expenses · posted Jan 16, 2026

Official filing document

 Bills named in this filing 2
  • HR 2484
    Seniors’ Access to Critical Medications Act of 2025
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
 Lobbying activity 1
Medicare/Medicaid

Legislation to stop restrictions to practices mailing oral drugs (HR 2484) Technical fix to the Inflation Reduction Act regarding drug negotiation (HR 4299) Increase in Medicare payments to physicians and an inflation update Legislative fixes to the 340B Drug Purchasing Program Site neutral payments to hospitals Misc legislation to stop pharmacy benefit manager patient abuses and low-ball reimbursement Prior authorization and step therapy issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem